APA

Kawano F., Tejima Y., Tajima H., Lee S. Y., Shiozaki A., Nakai R., Chyosa M., Sawada T., Maeda Y. & Mizokuni T. (19860916). [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia]. : [Rinsho ketsueki] The Japanese journal of clinical hematology.

Chicago

Kawano F, Tejima Y, Tajima H, Lee S Y, Shiozaki A, Nakai R, Chyosa M, Sawada T, Maeda Y and Mizokuni T. 19860916. [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia]. : [Rinsho ketsueki] The Japanese journal of clinical hematology.

Harvard

Kawano F., Tejima Y., Tajima H., Lee S. Y., Shiozaki A., Nakai R., Chyosa M., Sawada T., Maeda Y. and Mizokuni T. (19860916). [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia]. : [Rinsho ketsueki] The Japanese journal of clinical hematology.

MLA

Kawano F, Tejima Y, Tajima H, Lee S Y, Shiozaki A, Nakai R, Chyosa M, Sawada T, Maeda Y and Mizokuni T. [The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of relapsing or refractory cases of acute myelogenous leukemia]. : [Rinsho ketsueki] The Japanese journal of clinical hematology. 19860916.